183320-15-2

Usage

Uses

Used in Pharmaceutical Industry:
Desmethyl Erlotinib Acetate is used as an active pharmaceutical ingredient for the development of targeted cancer therapies. It is particularly effective against non-small cell lung cancer (NSCLC) and pancreatic cancer, which often exhibit EGFR mutations. The compound works by inhibiting the EGFR tyrosine kinase activity, thereby blocking the signaling pathways that promote cancer cell growth and proliferation.
Used in Research and Development:
In the field of research and development, Desmethyl Erlotinib Acetate serves as a valuable compound for studying the mechanisms of EGFR inhibition and its potential applications in cancer treatment. It can be used to investigate the structure-activity relationship of EGFR inhibitors and to develop novel, more potent, and selective inhibitors for cancer therapy.
Used in Drug Synthesis:
Desmethyl Erlotinib Acetate is also utilized as a key intermediate in the synthesis of other EGFR inhibitors and related compounds. Its chemical properties make it a suitable candidate for further modification and optimization to improve the efficacy, selectivity, and pharmacokinetic properties of EGFR-targeted drugs.